Travaux scientifiques

Uzm. Dr. Kadriye Başkurt

61 publications. La source de l’information est indiquée à côté de chaque publication.

Retour au profil
  1. Remnant cholesterol inflammatory index for predicting pathological complete response to neoadjuvant therapy in breast cancer: A multicenter external validation study

    The Breast, 2026

    DOI 10.1016/j.breast.2026.104936 PMID 42777557 Texte intégral en libre accèsSource : ORCID

  2. Serum Vitamin D as a Predictor of Immunotherapy Response in Advanced Non-small Cell Lung Cancer

    Acta haematologica oncologica Turcica., 2026

    DOI 10.4274/ahot.galenos.2026.2026-4-7 Texte intégral en libre accèsSource : OpenAlex

  3. Predicting Pathologic Response in Locally Advanced Rectal Cancer Using Inflammatory, Nutritional, and Sarcopenia-Based Markers: A Regression and AI-Based Analysis (CINR-AI Study)

    Clinical Colorectal Cancer, 2026

    DOI 10.1016/j.clcc.2025.10.002 PMID 41198426 1 citation (Europe PMC) Source : ORCID

  4. Baseline 25-hydroxyvitamin D and progression-free survival in de novo metastatic hormone-sensitive prostate cancer: prognostic model development and external validation

    The oncologist, 2026

    DOI 10.1093/oncolo/oyag396 PMID 42836684 Texte intégral en libre accèsSource : Europe PMC

  5. Integrated assessment of cachexia, body composition, and patient-reported outcomes in unplanned hospitalizations of patients with metastatic cancer (PRO-HAND study).

    Journal of Clinical Oncology, 2026

    DOI 10.1200/jco.2026.44.16_suppl.12075 Source : OpenAlex

  6. Clinicopathologic Characteristics, Treatment Patterns, and Survival Outcomes in Malignant Mesothelioma: A Population-based SEER Study, 2004-2023

    Journal of Oncological Sciences, 2026

    DOI 10.37047/jos.galenos.2026.2026-8-2 Texte intégral en libre accèsSource : OpenAlex

  7. Prognostic value of the lymphocyte‑albumin‑neutrophil ratio in de novo metastatic colorectal cancer: A continuous‑variable analysis

    Oncology Letters, 2026

    DOI 10.3892/ol.2026.15922 Texte intégral en libre accèsSource : OpenAlex

  8. Structural Acceleration in Sepsis-Associated Cancer Mortality in an Aging Population: A Nationwide Study in the United States, 1999–2020

    SSRN Electronic Journal, 2026

    DOI 10.2139/ssrn.6201853 Texte intégral en libre accèsSource : OpenAlex

  9. Temporal trends in venous thromboembolism–related mortality among gastric cancer deaths in the United States, 1999–2020.

    Turkish Journal of Clinics and Laboratory, 2026

    DOI 10.18663/tjcl.1893840 Texte intégral en libre accèsSource : OpenAlex

  10. Temporal Trends and Demographic Disparities in Prostate Cancer Mortality in the United States, 1999-2020: A CDC WONDER Analysis

    Acta haematologica oncologica Turcica., 2026

    DOI 10.4274/ahot.galenos.2026.2026-8-1 Texte intégral en libre accèsSource : OpenAlex

  11. Temporal Trends and Structural Acceleration in Nutritionand Cachexia-Associated Mortality Among Pancreatic Cancer Decedents in the United States, 1999–2020: A Nationwide Population-Based Joinpoint Analysis

    Eurasian Journal of Medical Investigation, 2026

    DOI 10.14744/ejmi.269441 Source : ORCID

  12. Wearable-derived postdischarge mobility as a digital biomarker for 90-day readmission and mortality in metastatic cancer

    Supportive Care in Cancer, 2026

    DOI 10.1007/s00520-026-11216-6 PMID 42726154 Source : OpenAlex

  13. Re: Factors associated with employment outcomes in cancer survivors: a systematic scoping review spanning a decade of international research

    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2026

    DOI 10.1007/s00520-026-10716-9 PMID 42043612 Source : Europe PMC

  14. Impact of vitamin D deficiency and inflammatory biomarkers on pathological response to neoadjuvant chemotherapy in breast cancer

    Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2026

    DOI 10.1007/s12094-025-04194-4 PMID 41525036 2 citations (Europe PMC) Source : Europe PMC

  15. Limb Compression Therapy and Chemotherapy-Induced Peripheral Neuropathy in Women With Gynecologic Cancers: A Prospective Self-Controlled Study(NEURO-GLOVE Trial)

    International journal of cancer, 2026

    DOI 10.1002/ijc.70601 PMID 42311202 Texte intégral en libre accèsSource : Europe PMC

  16. Limb compression therapy and chemotherapy-induced peripheral neuropathy in women with gynecologic cancers: A prospective self-controlled study (NEURO-GLOVE Trial)—Updated long-term analysis.

    Journal of Clinical Oncology, 2026

    DOI 10.1200/jco.2026.44.16_suppl.5545 Source : OpenAlex

  17. Topical Diclofenac for Prevention of Capecitabine-Induced Hand-Foot Syndrome: A Prospective Real-World Study

    JCO Global Oncology, 2026

    DOI 10.1200/go-26-00151 PMID 42623594 Texte intégral en libre accèsSource : OpenAlex

  18. Histologic Subtypes, Treatment Patterns, and Survival Outcomes in Cervical Cancer: A Population-based SEER Study

    Acta haematologica oncologica Turcica., 2026

    DOI 10.4274/ahot.galenos.2026.2026-7-1 Texte intégral en libre accèsSource : OpenAlex

  19. Impact of Zinc Supplementation and Topical Clobetasol on the Prevention of Regorafenib-Induced Hand-Foot Skin Reaction: The ZINCLO-HAND Study

    JCO Oncology Practice, 2026

    DOI 10.1200/op-26-00226 Source : OpenAlex

  20. Association between PhenoAge-assessed biological age and survival outcomes in solid tumor patients treated with immune checkpoint inhibitors

    Discover Oncology, 2026

    DOI 10.1007/s12672-026-05792-6 Texte intégral en libre accèsSource : ORCID

  21. Peer-led culinary workshops for cancer survivors: feasibility achieved, but stronger nutritional and evaluative foundations are required

    Supportive Care in Cancer, 2026

    DOI 10.1007/s00520-026-11053-7 PMID 42521889 Source : ORCID

  22. Real-World 30-Day Mortality After the Last Dose of Immune Checkpoint Inhibitors: A Multicenter Retrospective Cohort Study in Turkey

    Current Oncology, 2026

    DOI 10.3390/curroncol33060340 PMID 42346239 1 citation (Europe PMC) Texte intégral en libre accèsSource : ORCID

  23. Expanding perspectives on informed decision-making in pancreatic cancer

    Supportive Care in Cancer, 2026

    DOI 10.1007/s00520-026-10762-3 PMID 42090036 Source : ORCID

  24. Granülosit koloni stimülan faktörün yaygın evre küçük hücreli akciğer kanserinde etkinlik ve güvenilirliğinin retrospektif analizi

    Turkish Journal of Clinics and Laboratory, 2026

    DOI 10.18663/tjcl.1800650 Texte intégral en libre accèsSource : ORCID

  25. Metastatik/inoperabl pankreatikobilier sistem kanserlerinde ikinci basamak kemoterapilerin etkinlik ve güvenlilik sonuçları: tek merkez retrospektif çalışma

    Turkish Journal of Clinics and Laboratory, 2026

    DOI 10.18663/tjcl.1792552 Texte intégral en libre accèsSource : ORCID

  26. Trends in Overall Survival and Associated Factors in Metastatic Rectal and Rectosigmoid Cancer: A SEER-Based Cohort Study (2000-2022)

    Journal of Oncological Sciences, 2026

    DOI 10.37047/jos.galenos.2026.2025-10-11 Texte intégral en libre accèsSource : OpenAlex

  27. Comment on: “The effect of cancer response style on anxiety and depression levels in newly diagnosed lung cancer patients”

    Supportive Care in Cancer, 2026

    DOI 10.1007/s00520-026-11316-3 PMID 42842009 Source : OpenAlex

  28. Safety and efficacy of the FOLFOX regimen in patients with metastatic gastrointestinal cancers and severe hyperbilirubinemia: A real‑world experience

    Oncology Letters, 2026

    DOI 10.3892/ol.2026.15932 Texte intégral en libre accèsSource : OpenAlex

  29. Efficacy of anti-VEGF & anti-EGFRs in microsatellite instable (MSI-H) metastatic colorectal cancer, Turkish Oncology Group (TOG) study.

    Journal of Clinical Oncology, 2025

    DOI 10.1200/jco.2025.43.16_suppl.e15507 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  30. Efficacy of Anti-VEGF and Anti-EGFRs in Microsatellite Instable (MSI-H) Metastatic Colorectal Cancer in a Turkish Oncology Group (TOG) Cohort Study

    Current Oncology, 2025

    DOI 10.3390/curroncol32110639 PMID 41294701 1 citation (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  31. 3060eP Immunomodulatory effect of cisplatin versus carboplatin on tumor microenvironment and anti-PD-1 response: A multicenter real-world analysis

    Annals of Oncology, 2025

    DOI 10.1016/j.annonc.2025.08.3673 Texte intégral en libre accèsSource : OpenAlex

  32. Immunomodulatory Effect of First-Line Cisplatin Versus Carboplatin in Response to Second-Line Nivolumab Therapy in Metastatic Non-Small Cell Lung Cancer

    Cancer Investigation, 2025

    DOI 10.1080/07357907.2025.2598042 PMID 41451788 Source : OpenAlex

  33. Vitamin D serum level as a predictor of response to immunotherapy for non-small cell lung cancer.

    Journal of Clinical Oncology, 2025

    DOI 10.1200/jco.2025.43.16_suppl.e14563 Texte intégral en libre accèsSource : OpenAlex

  34. The Impact of Systemic Inflammation and Nutritional Indicators on Progression-Free Survival in Patients with Metastatic Clear Cell Renal Carcinoma Receiving First-Line Tyrosine Kinase Inhibitor Therapy

    Turkish Journal of Clinics and Laboratory, 2025

    DOI 10.18663/tjcl.1822329 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  35. 2881P Integrating inflammatory, nutritional, and sarcopenia-based biomarkers for predicting pathological response in rectal cancer patients receiving total neoadjuvant therapy: A regression and AI-supported approach

    Annals of Oncology, 2025

    DOI 10.1016/j.annonc.2025.08.3493 Texte intégral en libre accèsSource : OpenAlex

  36. 2864P Assessment of inflammation, nutrition and cachexia-related indices to predict 90-day mortality in hospitalized cancer patients

    Annals of Oncology, 2025

    DOI 10.1016/j.annonc.2025.08.3476 Texte intégral en libre accèsSource : OpenAlex

  37. 2814P AI-supported evaluation of clinical and biological risk indicators in cancer patients with unplanned hospitalisations

    Annals of Oncology, 2025

    DOI 10.1016/j.annonc.2025.08.3426 Texte intégral en libre accèsSource : OpenAlex

  38. Compression therapy for taxane-induced peripheral neuropathy: promising results undermined by methodological gaps

    Supportive Care in Cancer, 2025

    DOI 10.1007/s00520-025-10036-4 PMID 41099870 Source : ORCID

  39. Prognostic beliefs in palliative care: clarifying constructs, communicators, and consequences

    Supportive Care in Cancer, 2025

    DOI 10.1007/s00520-025-10060-4 PMID 41165945 Source : ORCID

  40. Prognostic significance of liver-to-muscle FDG uptake ratio and ınflammatory biomarkers in small cell lung cancer

    Clinical and Translational Oncology, 2025

    DOI 10.1007/s12094-025-04070-1 PMID 41053526 3 citations (Europe PMC) Source : ORCID

  41. Letter to the Editor: Comment on “Vitamin D Supplementation Improves Pathological Complete Response in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy”

    Nutrition and Cancer, 2025

    DOI 10.1080/01635581.2025.2514277 PMID 40481654 Source : ORCID

  42. Dissecting component-specific and sustained benefits of integrated psychosocial–nutritional care in gastric oncology

    Supportive Care in Cancer, 2025

    DOI 10.1007/s00520-025-09652-x PMID 40512231 Source : ORCID

  43. Prediction of 90-day mortality among cancer patients with unplanned hospitalisation: a retrospective validation study of three prognostic scores

    The Lancet Regional Health - Europe, 2025

    DOI 10.1016/j.lanepe.2025.101317 PMID 40672056 11 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

  44. Letter RE: Somatic BRCA1/2 mutations are associated with a similar survival advantage to their germline counterparts in tubo-ovarian high-grade serous carcinoma

    European Journal of Cancer, 2025

    DOI 10.1016/j.ejca.2025.115490 PMID 40335330 Source : ORCID

  45. Effect of a ChatGPT-based digital counseling intervention on anxiety and depression in patients with cancer: A prospective, randomized trial

    European Journal of Cancer, 2025

    DOI 10.1016/j.ejca.2025.115408 PMID 40215593 17 citations (Europe PMC) Source : ORCID

  46. Impact of sarcopenia on paclitaxel-induced peripheral neuropathy in early-stage breast cancer: a prospective observational study (the neuro-sarc study)

    Supportive Care in Cancer, 2025

    DOI 10.1007/s00520-025-10157-w PMID 41238950 1 citation (Europe PMC) Source : ORCID

  47. Unaccounted clinical factors in CINV outcomes: the missing role of IO therapy, metastatic sites, and prophylaxis strategy

    Supportive Care in Cancer, 2025

    DOI 10.1007/s00520-025-09631-2 PMID 40498135 Source : OpenAlex

  48. The Effect of Malnutrition on Treatment Efficacy and Toxicity in Geriatric Patients Treated With Immune Checkpoint Inhibitors

    Cancer Diagnosis & Prognosis, 2025

    DOI 10.21873/cdp.10491 PMID 41179320 Texte intégral en libre accèsSource : OpenAlex

  49. 2865P Association of skeletal muscle and visceral FDG uptake with cancer cachexia, nutritional status, and survival in small cell lung cancer

    Annals of Oncology, 2025

    DOI 10.1016/j.annonc.2025.08.3477 Texte intégral en libre accèsSource : OpenAlex

  50. 2867P Evaluation of the relationship between sarcopenia and paclitaxel toxicity in early stage breast cancer patients receiving adjuvant/neoadjuvant paclitaxel

    Annals of Oncology, 2025

    DOI 10.1016/j.annonc.2025.08.3479 Texte intégral en libre accèsSource : OpenAlex